Your browser doesn't support javascript.
loading
Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in Patients with Ulcerative Colitis.
Yoshida, Atsushi; Matsuoka, Katsuyoshi; Ueno, Fumiaki; Morizane, Toshio; Endo, Yutaka; Hibi, Toshifumi.
Afiliação
  • Yoshida A; Center for Gastroenterology and Inflammatory Bowel Disease, Ofuna Chuo Hospital, Kamakura, Japan.
  • Matsuoka K; Department of Gastroenterology and Hepatology, Toho University Sakura Medical Center, Chiba, Japan.
  • Ueno F; Center for Gastroenterology and Inflammatory Bowel Disease, Ofuna Chuo Hospital, Kamakura, Japan.
  • Morizane T; Center for Gastroenterology and Inflammatory Bowel Disease, Ofuna Chuo Hospital, Kamakura, Japan.
  • Endo Y; Center for Gastroenterology and Inflammatory Bowel Disease, Ofuna Chuo Hospital, Kamakura, Japan.
  • Hibi T; Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan.
Inflamm Intest Dis ; 6(2): 117-122, 2021 May.
Article em En | MEDLINE | ID: mdl-34124183
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article